Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for HYPD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2018. Start Trial.
Date Value
July 31, 2026 99.84%
June 30, 2026 99.84%
May 31, 2026 99.84%
April 30, 2026 99.84%
March 31, 2026 99.84%
February 28, 2026 99.84%
January 31, 2026 99.84%
December 31, 2025 99.84%
November 30, 2025 99.84%
October 31, 2025 99.84%
September 30, 2025 99.84%
August 31, 2025 99.84%
July 31, 2025 99.84%
June 30, 2025 99.84%
May 31, 2025 99.84%
April 30, 2025 99.84%
March 31, 2025 99.81%
February 28, 2025 99.75%
January 31, 2025 99.53%
December 31, 2024 98.90%
November 30, 2024 98.80%
October 31, 2024 94.04%
September 30, 2024 93.89%
August 31, 2024 93.72%
July 31, 2024 93.03%
Date Value
June 30, 2024 93.03%
May 31, 2024 93.03%
April 30, 2024 93.03%
March 31, 2024 86.69%
February 29, 2024 85.43%
January 31, 2024 85.43%
December 31, 2023 85.43%
November 30, 2023 85.43%
October 31, 2023 85.43%
September 30, 2023 84.52%
August 31, 2023 84.52%
July 31, 2023 84.52%
June 30, 2023 84.52%
May 31, 2023 84.52%
April 30, 2023 84.52%
March 31, 2023 84.52%
February 28, 2023 84.52%
January 31, 2023 84.52%
December 31, 2022 84.52%
November 30, 2022 84.42%
October 31, 2022 84.42%
September 30, 2022 84.42%
August 31, 2022 84.42%
July 31, 2022 83.12%
June 30, 2022 82.81%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Omeros Corp. 95.41%
Talphera, Inc. 99.48%
ANI Pharmaceuticals, Inc. 72.96%
Corcept Therapeutics, Inc. 71.85%
Veru, Inc. 99.12%